3LABOS - To Improve Infectious Disease Surveillance in France by Automated Biological Data Extraction from 3 Laboratories
Head :
Dubois Daniel
Last update : 07/07/2015 | Version : 1 | ID : 8403
| General | |
| Identification | |
| Detailed name | To Improve Infectious Disease Surveillance in France by Automated Biological Data Extraction from 3 Laboratories |
| Sign or acronym | 3LABOS |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | 1415428 v0 |
| General Aspects | |
| Medical area |
Biology Infectious diseases |
| Keywords | infectious diseases, laboratory test data, automated extraction, surveillance |
| Scientific investigator(s) (Contact) | |
| Name of the director | Dubois |
| Surname | Daniel |
| Address | 12 Rue du Val d’Osne, 94415 Saint-Maurice |
| DMI@invs.sante.fr | |
| Organization | Institut de veille |
| Collaborations | |
| Funding | |
| Funding status |
Public |
| Details | French Institute for Public Health Surveillance (InVS) |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | InVS |
| Organisation status |
Public |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Longitudinal study (except cohorts) |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Patients fulfilling the exclusion criteria. |
| Database objective | |
| Main objective |
Surveillance of infectious diseases through regular automated transfer of biological results from specialist biology laboratories to InVS.
To improve the surveillance of certain infectious diseases already monitored by another system: o To supplement surveillance data from other sources and to estimate completeness (particularly MDO). • To implement a sustainable monitoring system for unmonitored diseases as well as: o Monitoring spatial and temporal trends of targeted pathogens; o Providing individual data; o Contributing to epidemic investigations; o Identifying active movement areas. |
| Inclusion criteria | Individuals who have had biological samples taken for the following diseases: measles, chikungunya, dengue fever, tuberculosis, syphilis, Q fever, tick-borne encephalitis, leptospirosis, Lyme disease, psittacosis, toxoplasmosis. (CNIL file in progress for: hepatitis E, hepatitis A, rubella, lead poisoning, gonorrhoea and chlamydia). |
| Population type | |
| Age |
Newborns (birth to 28 days) Infant (28 days to 2 years) Early childhood (2 to 5 years) Childhood (6 to 13 years) Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
General population |
| Gender |
Male Woman |
| Geography area |
National |
| Detail of the geography area | France |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2012 |
| Size of the database | |
| Size of the database (number of individuals) |
Greater than 20 000 individuals |
| Details of the number of individuals | --- |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Biological data Administrative data |
| Biological data (detail) | Lab name, disease, laboratory test results: serology tests, CRP, etc. according to disease. |
| Administrative data (detail) | Patient data: anonymity code, date of birth, sex, post code, sample identifier. Laboratory: company name, address, post code, municipality, phone. Prescriber: surname, first name, address, post code, municipality, phone. |
| Presence of a biobank |
No |
| Health parameters studied |
Health care consumption and services Others |
| Care consumption (detail) |
Medical/paramedical consultation |
| Other (detail) | Biological test results. |
| Procedures | |
| Data collection method | Automated data extraction from 3 laboratories to InVS. Receipt of files per laboratory and disease at determined intervals (daily or monthly). |
| Quality procedure(s) used | Consistency controls during data transmission, statistical programmes. |
| Participant monitoring |
Yes |
| Details on monitoring of participants | Improved surveillance and investigations may be implemented for positive cases in relation to regional InVS units (CIREs), according to the monitored disease. |
| Links to administrative sources |
Yes |
| Linked administrative sources (detail) | The individual anonymity code from the 3Labos database is the same code used for obligatory notification. |
| Promotion and access | |
| Promotion | |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Contact the scientist in charge/Send data request form to InVS. |
